‘Knowledge is power’ for rare diseases and NAbsCure Rare Disease’s Rich Horgan discusses the importance of NAbs screening and helping rare disease patients better understand Share X‘Knowledge is power’ for rare diseases and NAbshttps://pharmaphorum.com/views-analysis-patients/knowledge-is-power-for-rare-diseases-and-nabs/
Surviving as a rare disease biotech during COVID-19With trial delays, social distancing, and falls in charitable funding, the coronavirus pandemic presents some serious challenges for Share XSurviving as a rare disease biotech during COVID-19https://pharmaphorum.com/r-d/views-analysis-r-d/surviving-as-a-rare-disease-biotech-during-covid-19/
